Reinhart Partners LLC. Lowers Holdings in Maximus, Inc. $MMS

Reinhart Partners LLC. decreased its holdings in Maximus, Inc. (NYSE:MMS) by 21.3% in the 4th quarter, Holdings Channel reports. The institutional investor owned 725,269 shares of the health services provider’s stock after selling 196,309 shares during the period. Maximus makes up approximately 1.9% of Reinhart Partners LLC.’s portfolio, making the stock its 27th biggest position. Reinhart Partners LLC.’s holdings in Maximus were worth $62,607,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in MMS. Royal Bank of Canada lifted its stake in shares of Maximus by 146.2% in the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock valued at $1,345,000 after purchasing an additional 11,716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after purchasing an additional 221 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Maximus by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock valued at $12,321,000 after purchasing an additional 11,754 shares in the last quarter. Jane Street Group LLC lifted its stake in shares of Maximus by 941.2% in the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after purchasing an additional 88,835 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new position in shares of Maximus in the 2nd quarter valued at about $204,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 742 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. The trade was a 3.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.80% of the company’s stock.

Maximus Price Performance

Shares of NYSE MMS opened at $60.90 on Wednesday. Maximus, Inc. has a twelve month low of $56.92 and a twelve month high of $100.00. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The company has a market capitalization of $3.20 billion, a price-to-earnings ratio of 9.12 and a beta of 0.58. The business has a 50 day simple moving average of $64.38 and a 200-day simple moving average of $77.15.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. During the same period in the previous year, the business earned $2.01 EPS. The business’s quarterly revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, equities research analysts expect that Maximus, Inc. will post 8.43 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Friday, May 15th. Maximus’s payout ratio is 19.76%.

Analysts Set New Price Targets

Several research firms recently commented on MMS. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Finally, Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Maximus has an average rating of “Hold”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.